CCND1 and breast carcinoma: In addition, stabilization of β-catenin and amplification of its target gene, cyclin D1, is documented in > 50% of breast carcinomas [11,12], suggesting that the downstream effectors of the Wnt cascade could also be activated through abnormalities in other signaling pathways.